Advo(k)ate Advisors, LLC – Trademark Portfolio
Entity Type: 16
Advo(k)ate Advisors, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 8 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include (K)LEAN, (K)OMPRESSION, DIS(K)RIMINATION, and ADVO(K)ATE ADVISORS. The owner is based in Birmingham, AL.
6801 Cahaba Valley Road, Suite 206
Birmingham, AL 35242
Showing of trademarks Trademarks
Trademark Classifications
Advo(k)ate Advisors, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Advo(k)ate Advisors, LLC have?
Advo(k)ate Advisors, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending, 1 abandoned.
What trademark classes does Advo(k)ate Advisors, LLC file in?
Advo(k)ate Advisors, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 45 (Legal & Security Services). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Advo(k)ate Advisors, LLC's most well-known trademarks?
Advo(k)ate Advisors, LLC's registered trademark portfolio includes well-known marks such as (K)LEAN, (K)OMPRESSION, DIS(K)RIMINATION, and ADVO(K)ATE ADVISORS. These are among 4 currently registered trademarks in the portfolio.
What is Advo(k)ate Advisors, LLC's trademark registration success rate?
Advo(k)ate Advisors, LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 3 applications are pending review.